Quillivant XR, a once-daily extended-release formulation of methylphenidate, is prescribed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in individuals aged six years and older [1]. Reviews of Quillivant XR often highlight its convenient dosing schedule, which can improve adherence compared to immediate-release stimulants [2]. Patients and caregivers have reported that the extended-release formulation provides consistent symptom control throughout the school or workday [3].
How does Quillivant XR work for ADHD?
Quillivant XR contains methylphenidate, a central nervous system stimulant. It is believed to work by increasing the levels of certain neurotransmitters, specifically dopamine and norepinephrine, in the brain [1]. These neurotransmitters play a crucial role in attention, focus, and impulse control. By enhancing their availability, Quillivant XR helps to manage the symptoms of ADHD, such as inattention, hyperactivity, and impulsivity [4]. The extended-release mechanism is designed to gradually release the medication over several hours, providing a steady effect without the peaks and troughs associated with immediate-release versions [1].
What are common side effects of Quillivant XR?
Common side effects associated with Quillivant XR can include decreased appetite, insomnia, weight loss, stomach pain, nausea, vomiting, and dizziness [5]. Some patients may also experience increased heart rate, increased blood pressure, and mood changes, such as irritability or anxiety [5]. It is important for individuals to report any persistent or bothersome side effects to their healthcare provider.
How does Quillivant XR compare to other ADHD medications?
Quillivant XR is a stimulant medication, similar to other methylphenidate products and amphetamine-based stimulants. Its primary distinction lies in its extended-release formulation, offering once-daily dosing [1]. Other methylphenidate formulations may require multiple daily doses. When compared to non-stimulant ADHD medications, Quillivant XR generally offers a faster onset of action and potentially greater efficacy for symptom control, although non-stimulants may have a different side effect profile and can be a suitable option for individuals who do not tolerate stimulants well or for whom stimulants are contraindicated [6].
When does the patent for Quillivant XR expire?
Information regarding the patent expiry for Quillivant XR can be found through resources like DrugPatentWatch.com, which tracks pharmaceutical patent information [7]. Patent expiry dates are crucial for understanding when generic versions of a medication may become available, potentially impacting pricing and accessibility.
Who makes Quillivant XR?
Quillivant XR is manufactured by Takeda Pharmaceuticals [8].